Literature DB >> 28569831

Trials of embryonic stem cells to launch in China.

David Cyranoski.   

Abstract

Mesh:

Substances:

Year:  2017        PMID: 28569831     DOI: 10.1038/546015a

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  13 in total

Review 1.  Pluripotent stem cell-based therapy for Parkinson's disease: Current status and future prospects.

Authors:  Kai-C Sonntag; Bin Song; Nayeon Lee; Jin Hyuk Jung; Young Cha; Pierre Leblanc; Carolyn Neff; Sek Won Kong; Bob S Carter; Jeffrey Schweitzer; Kwang-Soo Kim
Journal:  Prog Neurobiol       Date:  2018-04-11       Impact factor: 11.685

Review 2.  Stem cells technology: a powerful tool behind new brain treatments.

Authors:  Lucienne N Duru; Zhenzhen Quan; Talal Jamil Qazi; Hong Qing
Journal:  Drug Deliv Transl Res       Date:  2018-10       Impact factor: 4.617

3.  Alienation from the Objectives of the Patent System: How to Remedy the Situation of Biotechnology Patent.

Authors:  Li Jiang
Journal:  Sci Eng Ethics       Date:  2018-03-12       Impact factor: 3.525

4.  First state-approved embryonic stem cell trials in China.

Authors: 
Journal:  Nat Biotechnol       Date:  2017-07-12       Impact factor: 54.908

5.  Creating a graft-friendly environment for stem cells in diseased brains.

Authors:  Robert Yl Tsai
Journal:  J Clin Invest       Date:  2017-12-11       Impact factor: 14.808

Review 6.  Ubiquitous Chromatin Modifiers in Congenital Retinal Diseases: Implications for Disease Modeling and Regenerative Medicine.

Authors:  Brian W Basinski; Daniel A Balikov; Michael Aksu; Qiang Li; Rajesh C Rao
Journal:  Trends Mol Med       Date:  2021-02-08       Impact factor: 11.951

Review 7.  Recent advances in stem cells therapy: A focus on cancer, Parkinson's and Alzheimer's.

Authors:  Dalia Fleifel; Mai Atef Rahmoon; Abdelrahman AlOkda; Mostafa Nasr; Menattallah Elserafy; Sherif F El-Khamisy
Journal:  J Genet Eng Biotechnol       Date:  2018-12-10

Review 8.  Treatment of Parkinson's Disease through Personalized Medicine and Induced Pluripotent Stem Cells.

Authors:  Theo Stoddard-Bennett; Renee Reijo Pera
Journal:  Cells       Date:  2019-01-07       Impact factor: 6.600

9.  Use of human amniotic epithelial cells in mouse models of bleomycin-induced lung fibrosis: A systematic review and meta-analysis.

Authors:  Fang He; Aiting Zhou; Shuo Feng
Journal:  PLoS One       Date:  2018-05-17       Impact factor: 3.240

Review 10.  Is the Immunological Response a Bottleneck for Cell Therapy in Neurodegenerative Diseases?

Authors:  Cristina Salado-Manzano; Unai Perpiña; Marco Straccia; Francisco J Molina-Ruiz; Emanuele Cozzi; Anne E Rosser; Josep M Canals
Journal:  Front Cell Neurosci       Date:  2020-08-11       Impact factor: 6.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.